Plasma membrane cytoskeleton of muscle: A fine structural analysis

Microscopy Research and Technique

Volumn 48, Issue 3-4, 2000, Pages 131-141

  Watkins, Simon C ^a,d   Cullen, Michael J ^b   Hoffman, Eric P ^c   Billington, Lynn ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b NEWCASTLE UNIVERSITY   (United Kingdom)

^c Children's Medical Center   (United States)

^d UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Dystrophin; Dystrophin cytoskeleton; Electron microscopy; Light microscopy

Indexed keywords

ELECTRON MICROSCOPY; FIBERS; MOLECULES; MUSCLE; NITRIC OXIDE;

BASAL LAMINA; CYTOSKELETAL; CYTOSKELETONS; DUCHENNE MUSCULAR DYSTROPHIES; DYSTROPHIN; DYSTROPHIN CYTOSKELETON; EXTRACELLULAR; HOMOEOSTASIS; MUSCLE FIBER;

CELL MEMBRANES;

ALPHA ACTININ; DYSTROPHIN; NITRIC OXIDE SYNTHASE;

ARTICLE; CYTOSKELETON; DUCHENNE MUSCULAR DYSTROPHY; GENE MUTATION; HOMEOSTASIS; MUSCLE CONTRACTION; MUSCLE FIBER MEMBRANE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PROTEIN INTERACTION;

EID: 0033951650     PISSN: 1059910X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0029(20000201/15)48:3/4<131::AID-JEMT2>3.0.CO;2-G     Document Type: Article

References (131)

1. Abeysekera RM, Robards AW. 1995. Freeze-fracture artifacts: how to recognize and how to avoid them. In: Severs NJ, Shotton DM, editors. Rapid freezing freeze fracture, and deep etching. New York: Wiley-Liss. p 69-88.
2. Ahn AH, Freener CA, Gussoni E, Yoshida M, Ozawa E, Kunkle LM. 1996. The three human syntrophin genes are expressed in diverse tissues, have distinct chromosomal locations, and each bind to dystrophin and it relatives. J Biol Chem 271:2724-2730.
3. Ambrose HJ, Blake DJ, Nawrotzki RA, Davies KE. 1997. Genomic organization of the mouse dystrobrevin gene: comparative analysis with the dystrophin gene. Genomics 39:359-369.
4. Araishi K, Sasaoka T, Imamura M, Noguchi S, Kama Wakabayashi E, Yoshida M, Hori T, Ozawa E. 1999. Loss of the sarcoglycan complex and sarcospan leads to muscular dystrophy in beta-sarcoglycan-deficient mice. Hum Mol Genet 8:1589-1598.
5. Azibi K, Bachner L, Beckmann JS, Matsumura K, Hamouda E, Chaouch M, Chaouch A, Ait-Ouarab R, Vignal A, Weissenbach J, Vinet MC, Leturcq F, Collin H, Tome FM.S, Reghis A, Fardeau M, Campbell KP, Kaplan JC. 1993. Severe childhood autosomal recessive muscular dystrophy with the deficiency of the 50 kDA dystrophin-associated glycoprotein maps to chromosome 13q12. Hum Mol Genet 2:1423-1428.
6. Bach JR, McKeon J. 1991. Orthopedic surgery and rehabilitation for the prolongation of brace-free ambulation of patients with Duchenne muscular dystrophy. Am J Phys Med Rehabil 70:323-331.
7. Barton-Davis ER, Cordier L, Shoturma D, Leland SE, Sweeney HL. 1999. Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice. J Clin Invest 104:375-381.
8. Ben Hamida M, Fardeau, Attia N. 1983. Severe childhood muscular dystrophy affecting both sexes and frequent in Tunisia. Muscle Nerve 6:469-480.
9. Blake DJ, Nawrotzki R, Peters MF, Froehner S, Dacies KE. 1996. Isoform diversity of dystropbrevin, the murine 87-kDa postsynaptic protein. J Biol Chem 271:7802-7810.
10. Bowe MA, Deyst KA, Leszyk JD, Fallon JF. 1994. Identification and purification of an agrin receptor from Torpedo post-synaptic membranes: a heteomeric complex related to the dystroglycans. Neuron 7:499-508.
11. Brenman JE, Chao DS, Xia H, Aldape K, Bredt DS. 1995. Nitric acid synthase complexed with dystrophin and absent from skeletal muscle sarcolemma in Duchenne muscular dystrophy. Cell 82:743-752.
12. Campbell KP, Kahl SD. 1989. Association of dystroglycan and an integral membrane glycoprotein. Nature 338:259-262.
13. Carrie A, Piccolo F, Leturcq F, de Toma C, Azibi K, Beldjord C, Vallat JM, Merlini L, Voit T, Sewry C, Urtizberea JA, Romera N, Tome FM, Fardeau M, Sunada Y, Campbell KP, Kaplan JC, Jeanpierre M. 1997. Mutational diversity and hot spots in the alpha-sarcoglycan gene in autosomal recessive muscular dystrophy (LGMD2D). J Med Genet 34:470-475.
14. Castello A, Brocheriou V, Chafey P, Kahn A, Gilgenkrantz H. 1996. Characterization of the dystrophin-syntrophin interaction using the two-hybrid system in yeast. FEBS Lett. 383:124-128.
15. Chan Y, Kunkel LM. 1997. In vitro expressed dystrophin fragments do not associate with each other. FEBS Lett 410:153-159.
16. Chang WJ, Iannaccone ST, Lau KS, Masters BS.S, McCabe TJ, McMillian K, Padre RC, Spencer MJ, Tidball JC, Stull JT. 1996. Neuronal nitric oxide synthase and dystrophin-deficient muscular dystrophy. Proc NatlAcad Sci USA 93:9142-9147.
17. Coral-Vazquez R, Cohn RD, Moore SA, Hill JA, Weiss RM, Davisson RL, Straub V, Barresi R, Bansal. D, Hrstka RF, Williamson R, Campbell KP. 1999. Disruption of the sarcoglycan-sarcospan complex in vascular smooth muscle: a novel mechanism for cardiomyopathy and muscular dystrophy. Cell 20:465-474.
18. Crosbie RH, Heighway J, Venzke Lee JC, Campbell KP. 1997. Sarcospan, the 25-kDa transmembrane component of the dystrophin complex. J Biol Chem 272:31221-31224.
19. Crosbie RH, Straub V, Yun H-Y, Lee JC, Rafael JA, Chamberlain JS, Dawson V.L, Dawson TM, Campbell KP. 1998. mdx muscle pathology is independent of nNOS perturbation. Hum Mol Gen 7:823-829.
20. Crosbie RH, Lebakken CS, Holt KH, Venzke DP, Straub V, Lee JC, Grady RM, Chamberlain JS, Sanes JR, Campbell KP. 1999. Membrane targeting and stabilization of sarcospan is mediated by the sarcoglycan subcomplex. J Cell Biol 145:153-165.
21. Cullen MJ, Walsh J, Nicholson LV. 1994. Immunogold localization of the 43-kDA dystroglycan at the plasma membrane in control and dystrophic human muscle. Acta Neuropathol 87:349-354.
22. Cullen MJ, Walsh J, Stevenson SA, Rothery S, Severs NJ. 1998. Co-localization of dystrophin and β-dystroglycan demonstrated in en face view by double gold labeling of freeze-fractured skeletal muscle. J Histochem Cytochem 46:945-953.
23. DeSilva S, Drachman DB, Mellits D, Kunel RW. 1987. Prednisone treatment in Duchenne muscular dystrophy, long-term benefit. Arch Neurol 44:818-822.
24. Di Blasi. C, Morandi L, Barresi R, Blasevich F, Cornelio F, Mora M. 1996. Dystrophin-associated protein abnormalities in dystrophin-deficient muscle fibers from symptomatic and asymptomatic Duchenne/Becker muscular dystrophy carriers. Acta Neuropathol (Berl) 92:369-377.
25. Duclos F, Straub V, Moore SA, Venzke DP, Hrstka RF, Crosbie RH, Durbeej M, Lebakken CS, Ettinger AJ, van der Meulen J, Holt KH, Lim LE, Sanes JR, Davidson BL, Faulkner JA, Williamson R, Campbell KP. 1998. Progressive muscular dystrophy in α-dystroglycan deficient mice. J Cell Biol 142:1461-1471.
26. Durbeej M, Henry MD, Ferletta M, Campbell KP, Ekblom P 1998. Distribution of dystroglycan in normal adult mouse tissues. J Histochem Cytochem 46:449-457.
27. Ettinger AJ, Feng G, Sanes JR. 1997. epsilon-Sarcoglycan, a broadly expressed homologue of the gene mutated in limb-girdle muscular dystrophy 2D. J Biol Chem 272:32534-32538.
28. Ervasti JM, Campbell KP. 1993. Arole for the dystrophin-glycoprotein complex as a transmembrane linker between laminin and actin. J Cell Biol 122:809-823.
29. Ervasti JM, Ohlendeick K, Kahl SD, Gaver MG, Campbell KP. 1990. Deficiency of a glycoprotein component of the dystrophin complex in dystrophic muscle. Nature 345:315-359.
30. Fardeau M, Matsumura K, Tome FM, Collin H, Leturcq F Kaplan JC, Campbell KP. 1993. Deficiency of the 50 kDa dystrophin associated glycoprotein (adhalin) in severe autosomal recessive muscular dystrophies in children native from European countries. CR Acad Sci III 316:799-804.
31. Floyd SS Jr, Clemens PR, Ontell MR, Kochanek S, Day CS, Yang J, Hauschka SD, Balkir L, Morgan J, Moreland MS, Feero GW, Epperly M, Huard J. 1998. Ex vivo gene transfer using adenovirus-mediated full-length dystrophin delivery to dystrophic muscles. Gene Ther 5:19-30.
32. Forst J, Forst R. 1995. Importance of lower limb surgery in Duchenne muscular dystrophy. Arch Orthop Trauma Surg 114:106-111.
33. Forst J, Forst R. 1999. Lower limb surgery in Duchenne muscular dystrophy. Neuromusc Disord 9:176-181.
34. t 58,000 (58K) protein concentrated at acetlycholine receptor rich sites in Torpedo electroplaques and skeletal muscle. J Cell Biol 99:88-96.
35. Gee SH, Blacher RW, Douville PJ, Provost PR, Yurchenco PD, Carbonetto S. 1993. Laminin-binding protein 120 from brain is closely related to the dystrophin-associated glycoprotein, dystroglycan, and binds with high affinity to the major heparin binding domain of laminin. J Biol Chem 268:14792-14980.
36. Gee SH, Montaro F, Lindenbaum. MH, Carbonetto S. 1994. Dystroglycan-α dystrophin-associated glycoprotein, is a functional agrin receptor. Cell 77:675-678.
37. Greelish JP, Su LT, Lankford EB, Burkman JM, Chen H, Konig SK, Mercier IM, Desjardins PR, Mitchell MA, Zheng XG, Leferovich J, Gao GP, Balice-Gordon RJ, Wilson JM, Stedman HH. 1999. Stable restoration of the sarcoglycan complex in dystrophic muscle perfused with histamine and a recombinant adeno-associated viral vector. Nat Med 5:439-443.
38. Hack AA, Ly CT, Jiang F, Clendenin CC, Sigrist KS, Wollman RL, McNally EM. 1998. γ-sarcoglycan deficiency leads to muscle membrane defects and apoptosis independent of dystrophin. J Cell Biol 142:1279-1287.
39. Hance JE, Fu SY, Watkins SW, Beggs AH, Michalak M. 1999. α-actinm-2 is a new component of the dystrophin-glycoprotein complex. Arch Biochem Biophys 363:216-222.
40. Hassoni AA, Cullen MJ. 1999. Calcium homeostasis and ultrastructural studies in a patient with limb girdle muscular dystrophy type 2C. Neuropath Appl Neurobiol 25:244-253.
41. Hayashi YK, Mizuno Y, Yoshida M, Nonaka I, Ozawa E, Arahata K. 1995. The frequency of patients with 50-kD dystrophin-associated glycoprotein (50DAG or adhalin), deficiency in a muscular dystrophy patient population in Japan: immuncytochemical analysis of 50DAG, 43DAG, dystrophin, and utrophin. Neurology 45:551-554.
42. Haycock JW, MacNeil S, Jones P, Harris JB, Mantle D. 1996. Oxidative damage to muscle protein in Duchenne muscular dystrophy. Neuroreport. 8:357-361.
43. Haye A, Williams DA. 1994. Long-term clenbuterol administration alters the isometric contractile properties of skeletal muscle from normal and dystrophin-deficient mdx mice. Clin Exp Pharmacol Physiol 10:757-765.
44. Haye A, Williams DA. 1998. Examining potential drug therapies for muscular dystrophy utilizing dy/dy mouse:1. Clenbuterol. J Neurol Sci 157:122-128.
45. Higuchi I, Yamada N, Fukunaga H, Iwaki H, Okubo R, Nakagawa M, Osame M, Roberds SL, Shimuzu T, Campbell KP. 1994. Abnormal expression of laminin suggests disturbance of sarcolemma-extracel-lular matrix interaction in Japanese patients with autosomal recessive muscular dystrophy deficient on adhalin. J Clin Invest 94:601-606.
46. Higuchi I, Iwaki H, Kawai H, Endo T, Kunishige M, Fukunaga H, Nakagawa M, Aimura K, Osame M. 1997. New missence mutation in the alpha-sarcoglycan gene in a muscular dystrophy with incomplete alpha-sarcoglycan deficiency. J Neurol Sci 153:100-105.
47. Hoffman EP, Brown RH Jr, Kunkel LM. 1987. Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51:919-928.
48. Holt KH, Campbell KP. 1998. Assembly of the sarcoglycan complex: insights for muscular dystrophy. J Cell Biol 272:34667-34670.
49. Holt KH, Lim LE, Straub V, Venzke DP, Duclos F, Anderson RD, Davidson BL, Campbell KP. 1998. Functional rescue of the sarcoglycan complex in the BIO 14.6 hamster using delta sarcoglycan gene transfer. Mol Cell 1:841-848.
50. Howell JM, Lochmuller H, O'Hara A, Fletcher S, Kakulas BA, Massie B, Nalbantoglu J, Karpati G. 1998. High-level dystrophin expression after adeno-virus-mediated dystrophin minigene transfer to skeletal muscle of dystrophic dogs: prolongation of expression with immunosuppression. Hum Gene Ther 9:629-634.
51. Ibraghimov-Beskronova O, Ervasti JM, Leivielle CJ, Slaughter CA, Sernett SW, Campbell KP. 1992. Primary structure of dystrophin-associated glycoproteins linking dystrophin to the extracellular matrix. Nature 355:696-702.
52. James M, Nguyen TM, Wise CG, G.E. Jones GE, Morris GE. 1996. Utrophin, dystroglycan complex in membranes of adherent cultured cells. Cell Motil Cytoskeleton 33:163-174.
53. Jones KJ, Kin SS, North KN. 1998. Abnormalities of dystrophin, the sarcoglycans, and laminin α2 in the muscular dystrophies. J Med Gen 35:379-386.
54. Jung D, Yang B, Meyer J, Chamberlain JS, Campbell KP. 1995. Identification and characterization of the dystrophin anchoring site on β-dystroglycan. J Biol Chem 122:809-823.
55. Kameya S, Miyagoe Y, Nonaka I, Ikemoto T, Endo M, Hanaoka Nabeshima Y, Takeda S. 1999. α1-syntrophin gene disruption results in the absence of neuronal-type nitric-oxide synthase at the sarcolemma but does not induce muscle degeneration. J Biol Chem 274:2193-2200.
56. Karpati G. 1989. Nondystrophic myoblasts transplantation into dystrophic muscle. Muscle Nerve 12:337-339.
57. Karpati G, Petrof BJ. 1998. Adenovirus-mediated dystrophin minigene transfer improves muscle strength in adult dystrophic muscle (MDX) mice. Gene Ther 5:369-379.
58. Kawajiri M, Mitsui T, H. Kawai Kobunai T, Tsushihashi T, Saito S. 1996. Dystrophin, utrophin and β-dystroglycan expression in skeletal muscle from patients with muscular dystrophy. J Neuropath Exp Neurol 55:896-903.
59. Kawajiri M, Mitsui Kawai TH, Shono M, Matsumoto T. 1998. Quantitative analysis of immunofluorescent signals for dystrophin, β-dystroglycan and myosin in skeletal muscle by epifluorescent microscopy. Biotechnic Histochem 74:92-97.
60. Lagaurdriere-Gesbert C, LeNaour F, Lebel-Binay S, Billard M, Lemichez E, Boquet P, Boucheix C, Conjeaud H, Rubenstein E. 1997. Functional analysis of four tetraspans CD9 CD53 CD81, and CD82, suggests a common role in stimulation, cell adhesion, and migration: only CD9 upregulates HB-EGF activity. Cell Immunol 182:105-112.
61. Law PK, Goodwin TG, Fang Q, Deering MB, Duggirala V, Larkin C, Florendo JA, Cornett J, Li L, Shirzad A, Quinley T, Yoo TJ, Holcomb R. 1994. Whole body myoblast transfer. Transplant Proc 26:3381-3383.
62. Law PK, Goodwin TG, Fang Q, Deering MB, Duggirala V, Karkin C, Florendo JA, Jirky DS, Li HJ, Chen M, Cornett J, Li L, Shirzad A, Quinley. T, Yoo TJ, Holcomb R. 1993. Cell transplantation as an experimental treatment for Duchenne muscular dystrophy. Cell Transplant 2:485-505.
63. Li J, Dressman D, Tsao YP, Sakamoto A, Hoffman EP, Xiao X. 1999. RAAV vector-mediated sarcoglycan transfer in a hamster model for limb girdle muscular dystrophy. Gene Ther 6:74-82.
64. Madhavan R, Jarrett HW. 1995. Interactions between dystrophin-glycoprotein complex proteins. Biochemistry 34:12204-12209.
65. Maecker HT, Todd SC, Levy S. 1997. The tetraspan superfamily: molecular facilitators. FASEB 11:428-442.
66. Matsumura K, Campbell KP. 1994. Dystrophin-glycoprotein complex: its role in the molecular pathogenesis of muscular dystrophies. Muscle Nerve 17:2-15.
67. Matsumura K, Tome FM, Collon H, Azibi K, Chouch M, Kaplan JC, Fardeau M, Campbell KP. 1992a. Deficiency of the 50K dystrophin-associated glycoprotein in severe childhood autosomal recessive muscular dystrophy. Nature 359:320-322.
68. Matsumura K, Ervasti JM, Ohlendieck K, Kahl SD, Campbell KP. 1992b. Association of dystrophin-related protein with dystrophin-associated proteins in mdx mouse muscle. Nature 360:588-591.
69. Matsumura K, Ohlendieck K, Ionasescu V.V, Tome FM, Nonaka I, Burghes AH, Mora M, Kaplan JC, Fardeau M, Campbell KP. 1993a. Mild deficiency of dystrophin-associated proteins in Becker muscular dystrophy patients having in-frame deletions in the rod domain of dystrophin. Am J Hum Genet 53:409-416.
70. Matsumura K, Ohlendieck K, Ionasescu V.V, Tome FM, Nonaka I, Burghes AH, Mora M, Kaplan JC, Fardeau M, Campbell KP. 1993b. The role of the dystrophin-glycoprotein complex in the molecular pathogenesis of muscular dystrophies. Neuromusc Disord 3:533-535.
71. McNally EM, Bonnemann CG, Kunkle LM, Bhattacharya SK. 1994. Human adhalin is alternatively spliced and the gene is located on chromosome 17q21. Proc Natl Acad Sci USA 91:9690-9694.
72. McNally EM, Chantai TL, Kunkel LM. 1998. Human ∈-sarcoglycan is highly related to α-sarcoglycan (adhalin), the limb girdle muscular dystrophy 2D gene. FEBS Lett 422:27-32.
73. Metzinger L, Blake DJ, Squier MV, Anderson LV, Deconinck AE, Nawrotzki R, Hilton-Jones D, Davies KE. 1997. Dystrobrevin deficiency at the sarcolemma of patients with muscular dystrophy. Hum Mol Genet 6:1185-1191.
74. Miller RG, Sharma KR, Pavlath GK, Gussoni E, Mynhier M, Lanctot AM, Greco CM, Steinman L, Blau HM. 1997. Myoblast implantation in Duchenne muscular dystrophy: the San Franscisco study. Muscle Nerve 20:469-478.
75. Mizuno Y, Yoshida M, Nonaka I, Hirai S, Ozawa E. 1994. Expression of utrophin (dystrophin-related protein) and dystrophin-associated glycoproteins in muscles from patients with Duchenne muscular dystrophy. Muscle Nerve 17:206-216.
76. Mizuno Y, Noguchi S, Yamamoto H, Yoshida M, Nonaka I, Hirai S, Ozawa E. 1995. Sarcoglycan complex is selectively lost in dystrophic muscle. Am J Pathol 146:530-536.
77. Montanaro F, Carbonetto S Campbell KP, Lindenbaum M. 1995. Dystroglycan expression in the wild type and mdx mouse neural retina: synaptic colocalization with dystrophin, dystrophin related protein but not laminin. J Neurosci Res 42:527-538.
78. Montanaro F, Lindenbaum M, Carbonetto S. 1999. α-dystoglycan is a laminin receptor involved in extracellular matrix assembly on myotubes and muscle cell viability. J Cell Biol 145:1325-1340.
79. Nawrotzki R, Loh NY, Ruegg MA, Davies KE, Blake DJ. 1998. Characterisation of α-dystrobrevin in muscle. J Cell Sci 111:2595-2605.
80. Noguchi S, McNally EM, Ben Otmane K, Hagiwara Y, Mizuno Y, Yoshida M, Yamamoto H, Bonnemann CG, Gussoni E, Deton PH, Kyriakides T, Middleton L, Hentati F, Ben Hamida M, Nonaka. I, Vance JM, Kunkle LM, Ozawa E. 1995. Mutations in the dystrophin-associated protein gamma-sarcoglycan in chromosome 13 muscular dystrophy. Science 270:819-822.
81. Ohlendieck K. 1996. Towards an understanding of the dystrophin-glycoprotein complex: linkage between the extracellular matrix and the membrane cytoskeleton in muscle fibers. Eur J Cell Biol 69:1-10.
82. Ohlendieck K, Campbell KP. 1991. Dystrophin-associated proteins are greatly reduced in skeletal muscle from mdx mice. J Cell Biol 115:1685-1694.
83. Otey CA, Pavalko FM, Burridge K. 1990. An interaction between α-actinin and the β1 integrin subunit in vitro. J Cell Biol 111:721-729.
84. Ozawa E, Yoshida M, Suzuki A, Mizuno Y, Hagiwara Y, Noguchi S. 1995. Dystrophin-associated proteins in muscular dystrophy. Hum Mol Genet 4:1711-1716.
85. Passos-Bueno MR, Oliveira JR, Bakker E, Anderson RD, Marie SK, Vainzof M, Roberds S, Campbell KP, Zatz M. 1993a. Genetic heterogeneity of Duchenne-like muscular dystrophy (DLMD) based on linkage and 50 DAG analysis. Hum Mol Genet 2:1945-1947.
86. Passos-Bueno MR, Richard I, Vainzof M, Fougerousse F Weissenbach J, Broux O, Cohen D, Akiyama J, Marie SK, Carvalho AA. 1993b. Evidence of genetic hetreogeneity in the autosomal recessive adult forms of limb-girdle muscular dystrophy following linkage analysis with 15q probes in Brazilian families. J Med Genet 30:385-387.
87. Passos-Bueno MR, Moreira ES, Vainzof, M Marie SK, M. Zatz M. 1996. Linkage analysis in autosomal recessive limb-girdle muscular dystrophy (AR LGMD) maps a sixth form to 5q33-34 (LGMD2F) and indicates that there is at least one more subtype of AR LGMD. Hum Mol Genet 5:815-820.
88. Passos-Bueno MR, Vainzof M, Moreira ES, Zatz M. 1999. Seven autosomal recessive limb-girdle muscular dystrophies in the Brazilian population: from LGMD2A to LGMD2G. Am J Med Genet 82:392-398.
89. Pavalko FM, Otey CA, Simon KO, Burridge K. 1990. α-actinin; a direct link between actin and integrins. Biochem Soc Trans 19:1065-1069.
90. Peng HB, Ali AA, Daggett DF, Rauvala H, Hassel JR, Smalheiser NR. 1998. The relationship between perlecan and dystroglycan and its implication in the formation of the neuromuscular junction. Cell Adhesion Comm 5:475-489.
91. Peng HB, Xie H, Rossi SG, Rotundo RL. 1999. Acetylcholinesterase clustering at the neuromuscular junction involves perlecan and dystroglycan. J Cell Biol 145:911-921.
92. Peters MF, Kranmarcy NR, Sealock R, Froehner SC. 1994. β2 dystrophin: localization at the neuromuscular junction in skeletal muscle. Neuroreport 5:1577-1580.
93. Peters MF, Sadoulet-Puccio HM, Grady MR, Kramarcy NR, Kunkel LM, Sanes JR, Sealock R, Froehner SC. 1998. Differential membrane localization and intermolecular associations of alpha-dystrobrevin isoforms in skeletal muscle. J Cell Biol 142:1269-1278.
94. Puca AA, Nigro V, Piluso G, Belsito A, Sampaolo S, Quaderi N, Rossi E, Di Iorio G, Ballabio A, Franco B. 1998. Identification and characterization of a novel member of the dystrobrevin family. FEBS Lett 425:7-13.
95. Rybakova IN, Ervasti JM. 1997. Dystrophin-glycoprotein complex is monomeric and stabilizes actin filaments in vitro through lateral association. J Biol Chem 272:28772-29778.
96. Rambukkana A, Yamada H, Zanazzi G, Mathus T, Salzer JL, Yurchenco PD, Campbell KP, Fischetti VA. 1998. Role of alpha-dystroglycan as a Schwann cell receptor for Mycobacterium leprae. Science 282:2076-2079.
97. Roberds SL, Anderson RD, Ibraghimov-Beskrovnaya O, Campbell KP. 1993. Primary structure and muscle-specific expression of the 50-kDA dystrophin-associated glycoprotein (adhalin). J Biol Chem 268:23739-23742.
98. Rowland LP. 1981. Biochemistry of muscle membranes in Duchenne muscular dystrophy. Muscle Nerve 3:3-20.
99. Romero NB, Tome FM, Leturcq F, el Kerch FE, Azibi K, Bachner L, erson RD, Roberds SL, Campbell KP, Fardeau M, Kaplan JC. 1994. Genetic heterogeneity of severe childhood autosomal recessive muscular dystrophy with adhalin (50 kDa dystrophin-associated glycoprotein) deficiency. CR Acad Sci III 317:70-76.
100. Sadoulet-Puccio HM, Khurana TS, Cohen JB, Kunkel LM. 1996. Cloning and characterization of the human homolog of a dystrophin related phosphoprotein found at the Torpedo electric organ post-synaptic membrane. Hum Mol Genet 5:489-496.
101. Sadoulet-Puccio HM, Rajala M, Kunkel LM. 1997. Dystrobrevin and dystrophin: an interaction through coiled-coil motifs. Proc Natl Acad Sci USA 94:12413-12418.
102. Sakamoto A, Ono K, Abe M, Jasmin G, Eki T, Murakami Y, Masaski T, Toyo-oka T, Hanaoka F. 1997. Both hypertrophis and dilated cardiomyopathies are caused by mutation of the same gene, delta-sarcoglycan, in hamster: an animal model of disrupted dystrophin-associated glycoprotein complex. Proc Natl Acad Sci USA 94:13873-13878.
103. Salih MA, Omer MI, Bayoumi RA, Karrar O, Johnson M. 1993. Severe autosomal recessive muscular dystrophy in an extended Sudanese kindred. De Med Child Neurol 25:43-52.
104. Salih AM, Al-Nasser M, Ozo CO, Al-Turaniki MHS. 1996. Muscular dystrophy associated with β-dystroglycan deficiency. Ann Neurol 40:925-928.
105. Sansome A, Royston P, Dubowitz V. 1993. Steroids in Duchenne muscular dystrophy. Neuromusc Disord 3:567-569.
106. Smalheiser NR, Kim E. 1995. Purification of cranin, a laminin-binding membrane protein: identity with dystroglycan and reassessment of its carbohydrate moieties. Biol Chem 270:15425-15433
107. Smith SE, Green NE, Cole RJ, Robison JD, Fenichel GM. 1993. Prolongation of ambulation in children with Duchenne muscular dystrophy by subcutaneous lower limb tenotomy. J Pediatr Orthop 13:336-340.
108. Straub V, Duclos F, Venzke DP, Lee JC, Cutshall S, Leveille CJ, Campbell KP. 1998. Molecular pathogenesis of muscle degeneration in the delta-sarcoglycan-deficient hamster Am J Pathol. 153:1623-1630.
109. Sugiyama J Bowen DC, Hall ZW. 1994. Dystroglycan binds nerve and muscle agrin. Neuron 13:103-115.
110. Suzuki A, Yoshida M, Hayashi K, Mizuno Y, Hagiwara Y, Ozawa E. 1994. Molecular organization at the glycoprotein-complex binding site of dystrophin. Three dystrophin-associated proteins bind directly to the carboxy-terminal portion of dystrophin. Eur J Biochem 220:283-292.
111. Suzuki A, Yoshida M, Ozawa E. 1995. Mammalian alpha 1-and beta 1-syntrophin bind to the alternative splice-prone region of the dystrophin COOH terminus. J Cell Biol 128:373-381.
112. Tachi N, Ohya K, Chiba S, Matsuo M, Patria SY, Matsumura K. 1997. Deficiency of syntrophin, dystroglycan, and merosin, in a female infant with a congenital muscular dystrophy phenotype lacking cysteine-rich and C-terminal domains of dystrophin. Neurology 49:579-583.
113. Talts JF, Andac Z, Göhring W, Brancaccio A, Timpl R. 1999. Binding of the G domains of laminin α1 and α2 chains and perlecan to heparin, sulfatides, α-dystroglycan and several matrix proteins. EMBO J 18:863-870.
114. Tian M, Jacobson C, Gee SH, Campbell KP, Carbonetto S, Jucker M. 1996. Dystroglycan in the cerebellum is a laminin alpha 2-chain binding protein at the glial-vascular interface and is expressed in Purkinje cells. Eur J Neurosci 8:2739-2747.
115. Tremblay JP, Malouin F, Roy R, Huard J, Bouchard JP, Satoh A, Richards CL. 1993. Results of a triple blind clinical study of myoblasts transplnatations without immunosuppressive treatment in young boys with Duchenne muscular dystrophy. Cell Transplant 2:99-112.
116. Vainzof M, Passos-Bueno MR, Pavanello RC, Marie SK, Oliveira AS, Zatz M. 1999a. Sarcanoglycanopathies are responsible for 68% of severe autosomal recessive limb-girdle muscular dystrophy in the Brazilian population. J Neurol Sci 164:44-49.
117. Vainzof M, Moreira ES, Ferras G, Passos-Bueno MR, Marie SK, Zatz M. 1999b. Further evidence for the organization of the four sarcoglycans proteins within the dystrophin-glycoprotein complex. Eur J Hum Gen 7:251-254.
118. Vater R, Harris JB, erson V.B, Robreds SL, Campbell KP, Cullen MJ. 1995. The expression of dystrophin-associated glycoproteins during skeletal muscle degeneration and regeneration. An immunofluorescent study. J Neuropathol Exp Neurol 54:557-569.
119. Wakayama Y, Inoue M, Murahashi M, Shibuya S, Himi T, Kojimo H, Oniki H. 1997. Ultrastructural localization of α1-syntrophin and neuronal nitric oxide synthase in normal skeletal myofiber, and their relationship to each other and to dystrophin. Acta Neuropathol 94:455-464.
120. Wakayama Y, Inoue M, Kojima H, Murahashi M, Shibuya S, Jimi T, Hara H, Oniki H. 1999. Untrasructural localization of α-, β-, and γ-sarcoglycan and their mutual relationship to dystrophin, β-dystroglycan and β-spectrin in normal skeletal myofiber. Acta Neuropathol 97:288-286.
121. Wice BM, Gordon JI. 1995. A tetraspan membrane glycoprotein produced in the human intestinal epithelium and liver that can regulate cell density-dependent cell proliferation. J Biol Chem 270:21907-21918.
122. Williamson RA. Henry M Daniels KJ, Hrstka RF, Lee JC. Sunada Y Ibraghimov-Beskrovnaya O, Campbell KP. 1997. Dystroglycan is essential of early embryonic development: disruption of Reichert's membrane in Dagl-null mice. Hum Mol Gen 6:831-841.
123. Winder SJ, Gibson TJ, Kendrick-Jones J. 1995. Dystrophin and utrophin: the missing links! FEBS Lett 369:27-33.
124. Winder SJ, Gibson T, Kendrick-Jones J. 1996. Low probability of dystrophin and utrophin coiled regions forming dimers. Biochem Soc Trans 24:2808.
125. Wright MD, Tomlinson MG. 1994. The ins and outs of the transmembrane 4 superfamily. Immunol Today 15:588-594.
126. Yamada H, Shimuzu T, Tanaka T, Campbell KP, Matsumura K. 1994. Dystroglycan is a binding protein of laminin and merosin in peripheral nerve. FEBS Lett 352:49-53.
127. Yamaguchi M, M. Izumimoto M Robson RM, M.H. Stromer MH. 1985. Fine structure of wide and narrow vertebrate muscle Z-lines. A proposed model and computer model of Z-line architecture. J Mol Biol 184:621-644.
128. Yamamoto H, Hagiwara Y, Mizuno Y, Yoshida M, Ozawa E. 1993. Heterogeneity of dystrophin-associated proteins. J Biochem 114:132-139.
129. Yamamoto H, Mizuno Y, Hayashi K, Nonaka I, Yoshida M, Ozawa E. 1994. Expression of syntrophin-associated protein 35DAG and 50DAG (A2) is confined to striated muscles. J Biochem (Tokyo) 115:162-167.
130. Yang B, Jung D, Rafael JA, Chamberlain JS, Campbell KP. 1995. Identification of α-syntrophin binding to syntrophin triplet, dystrophin, and utrophin. J Biol Chem 10:4975-4978.
131. Yoshida M, Ozawa E. 1990. Glycoprotein complex anchoring dystrophin to sarcolemma. J Biochem 108:748-742.